Risk assessment of heavy metal toxicity induced by platinum accumulation in tumor patients
PeerJ · 2025
DOI: 10.7717/peerj.19375 ↗Kurz gefasst
Fachartikel in der Zeitschrift PeerJ, 2025. Verfasst von Yuling Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute of Clinical Pharmacy, Shantou University Medical College, Shantou, Guangdong, China. Hauptthemen laut MEDLINE: Carboplatin, Cisplatin, Neoplasms, Antineoplastic Agents. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Guangdong Provincial Basic and Applied Basic Research, Guangdong Provincial Medical Research.
Abstract (Originalsprache)
Background
Many studies have focused on adverse reactions caused by platinum drugs but neglected subsequent toxicities and the mechanisms during patient recovery after chemotherapy with different platinum drugs, which need attention because of the heavy metal platinum.
Objectives
We aimed to explore the correlations between platinum accumulation, hematological indices, and clinical toxicity in patients after a metabolism period following platinum drug chemotherapy, to better understand real-world clinical toxicity caused by platinum accumulation.
Methods
We enrolled patients receiving platinum chemotherapy, specifically cisplatin, oxaliplatin, or carboplatin. On the 25th day post-chemotherapy, we measured serum platinum concentrations and hematological indices, documented clinical toxicities, and subsequently performed correlation analyses.
Results
The serum platinum concentrations in oxaliplatin-, cisplatin-, and carboplatin-treated patients were 208.60, 349.15 and 211.30 µg/L ( χ 2 = 51.755, p < 0.001), respectively. Mediation effect analysis showed that decreased erythrocyte, hemoglobin and glutamic-pyruvic transaminase individually mediated 21.39, 12.0 and 10.94%, respectively, of the platinum positive effect on fatigue. Decreased erythrocyte counts mediated 5.89%, while increased creatinine mediated 5.2% of the platinum positive effect on adverse reactions. The cutoff values of hematological indices, the risk of adverse reactions and fatigue were also obtained in this research which will be applied in clinical practice. Discussion and Conclusions Platinum accumulation, by disrupting the red blood cell system and liver and kidney function, influences fatigue severity and common adverse reactions in patients during the post-chemotherapy recovery period.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Institute of Clinical Pharmacy, Shantou University Medical College, Shantou, Guangdong, China.
- Department of Preventive Medicine, Shantou University Medical College, Shantou, Guangdong, China.
- Pharmacy Intravenous Admixture Service, Cancer Hospital of Shantou University Medical College, Shantou, Guangdong, China.
- Department of Clinical Laboratory Medicine, Cancer Hospital of Shantou University Medical College, Shantou, Guangdong, China.
- Pharmacy Department, Cancer Hospital of Shantou University Medical College, Shantou, Guangdong, China.
Förderung
- Guangdong Provincial Basic and Applied Basic Research
- Guangdong Provincial Medical Research
Zitieren
APA
Zhang, Y., Guo, P., Huang, X., Xu, Y. W., Zheng, Z., & Fang, L. (2025). Risk assessment of heavy metal toxicity induced by platinum accumulation in tumor patients. PeerJ. https://doi.org/10.7717/peerj.19375
Vancouver
Zhang Y, Guo P, Huang X, Xu YW, Zheng Z, Fang L. Risk assessment of heavy metal toxicity induced by platinum accumulation in tumor patients. PeerJ. 2025. doi:10.7717/peerj.19375
BibTeX
@article{Zhang2025,
author = {Zhang, Yuling and Guo, Pi and Huang, Xiaoting and Xu, Yi-Wei and Zheng, Zhiwei and Fang, Ling},
title = {Risk assessment of heavy metal toxicity induced by platinum accumulation in tumor patients},
journal = {PeerJ},
year = {2025},
doi = {10.7717/peerj.19375}
}
EUVIMED